104 related articles for article (PubMed ID: 36387201)
21. Detecting Dysglycemia Using the 2015 United States Preventive Services Task Force Screening Criteria: A Cohort Analysis of Community Health Center Patients.
O'Brien MJ; Lee JY; Carnethon MR; Ackermann RT; Vargas MC; Hamilton A; Mohanty N; Rittner SS; Park JN; Hassan A; Buchanan DR; Liu L; Feinglass J
PLoS Med; 2016 Jul; 13(7):e1002074. PubMed ID: 27403739
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of the Benefits and Harms of Lung Cancer Screening With Low-Dose Computed Tomography: Modeling Study for the US Preventive Services Task Force.
Meza R; Jeon J; Toumazis I; Ten Haaf K; Cao P; Bastani M; Han SS; Blom EF; Jonas DE; Feuer EJ; Plevritis SK; de Koning HJ; Kong CY
JAMA; 2021 Mar; 325(10):988-997. PubMed ID: 33687469
[TBL] [Abstract][Full Text] [Related]
23. Performance of the 2015 US Preventive Services Task Force Screening Criteria for Prediabetes and Undiagnosed Diabetes.
O'Brien MJ; Bullard KM; Zhang Y; Gregg EW; Carnethon MR; Kandula NR; Ackermann RT
J Gen Intern Med; 2018 Jul; 33(7):1100-1108. PubMed ID: 29651678
[TBL] [Abstract][Full Text] [Related]
24. Effects of medicare part d on disparity implications of medication therapy management eligibility criteria.
Wang J; Qiao Y; Shih YC; Jamison JJ; Spivey CA; Li L; Wan JY; White-Means SI; Dagogo-Jack S; Cushman WC; Chisholm-Burns M
Am Health Drug Benefits; 2014 Sep; 7(6):346-58. PubMed ID: 25558303
[TBL] [Abstract][Full Text] [Related]
25. Proportion of Non-Small-Cell Lung Cancer Patients that Would Have Been Eligible for Lung Cancer Screening.
Wu GX; Goldstein L; Kim JY; Raz DJ
Clin Lung Cancer; 2016 Sep; 17(5):e131-e139. PubMed ID: 26872765
[TBL] [Abstract][Full Text] [Related]
26. Estimating Eligibility for Lung Cancer Screening by Neighborhood in Philadelphia Using Previous and Current USPSTF Guidelines.
McIntire RK; Lewis E; Zeigler-Johnson C; Shusted C; Barta J; Juon HS; Keith SW; Klein G
Popul Health Manag; 2022 Apr; 25(2):254-263. PubMed ID: 35442796
[TBL] [Abstract][Full Text] [Related]
27. Improving identification of candidates for lung cancer screening in a high risk population.
Waddle MR; Ko SJ; May J; Kaleem T; Miller DH; Stross WC; Malouff TD; Wert K; Cuthbert K; Landy R; Strong G; Vallow LA; Johnson MM
Lung Cancer; 2020 Oct; 148():79-85. PubMed ID: 32827761
[TBL] [Abstract][Full Text] [Related]
28. Improving Lung Cancer Screening Selection: The HUNT Lung Cancer Risk Model for Ever-Smokers Versus the NELSON and 2021 United States Preventive Services Task Force Criteria in the Cohort of Norway: A Population-Based Prospective Study.
Nguyen OTD; Fotopoulos I; Markaki M; Tsamardinos I; Lagani V; Røe OD
JTO Clin Res Rep; 2024 Apr; 5(4):100660. PubMed ID: 38586302
[TBL] [Abstract][Full Text] [Related]
29. Brief Report: Risk Prediction Model Versus United States Preventive Services Task Force 2020 Draft Lung Cancer Screening Eligibility Criteria-Reducing Race Disparities.
Pasquinelli MM; Tammemägi MC; Kovitz KL; Durham ML; Deliu Z; Rygalski K; Liu L; Koshy M; Finn P; Feldman LE
JTO Clin Res Rep; 2021 Mar; 2(3):100137. PubMed ID: 34590000
[TBL] [Abstract][Full Text] [Related]
30. Disparities in Meeting USPSTF Breast, Cervical, and Colorectal Cancer Screening Guidelines Among Women in the United States.
Benavidez GA; Zgodic A; Zahnd WE; Eberth JM
Prev Chronic Dis; 2021 Apr; 18():E37. PubMed ID: 33856975
[TBL] [Abstract][Full Text] [Related]
31. There are no randomized controlled trials that support the United States Preventive Services Task Force Guideline on screening for depression in primary care: a systematic review.
Thombs BD; Ziegelstein RC; Roseman M; Kloda LA; Ioannidis JP
BMC Med; 2014 Jan; 12():13. PubMed ID: 24472580
[TBL] [Abstract][Full Text] [Related]
32. American College of Cardiology/American Heart Association (ACC/AHA) Class I Guidelines for the Treatment of Cholesterol to Reduce Atherosclerotic Cardiovascular Risk: Implications for US Hispanics/Latinos Based on Findings From the Hispanic Community Health Study/Study of Latinos (HCHS/SOL).
Qureshi WT; Kaplan RC; Swett K; Burke G; Daviglus M; Jung M; Talavera GA; Chirinos DA; Reina SA; Davis S; Rodriguez CJ
J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28495699
[TBL] [Abstract][Full Text] [Related]
33. Association of the USPSTF Grade D Recommendation Against Prostate-Specific Antigen Screening With Prostate Cancer-Specific Mortality.
Burgess L; Aldrighetti CM; Ghosh A; Niemierko A; Chino F; Huynh MJ; Efstathiou JA; Kamran SC
JAMA Netw Open; 2022 May; 5(5):e2211869. PubMed ID: 35576008
[TBL] [Abstract][Full Text] [Related]
34. Reasons for Exclusion from a Smoking Cessation Trial: An Analysis by Race/Ethnicity.
Webb Hooper M; Asfar T; Unrod M; Dorsey A; Correa JB; Brandon KO; Simmons VN; Antoni MA; Koru-Sengul T; Lee DJ; Brandon TH
Ethn Dis; 2019; 29(1):23-30. PubMed ID: 30713413
[TBL] [Abstract][Full Text] [Related]
35. Health utilities for participants in a population-based sample who meet eligibility criteria for lung cancer screening.
Ngo PJ; Wade S; Vaneckova P; Behar Harpaz S; Caruana M; Cressman S; Tammemagi M; Karikios D; Canfell K; Weber MF
Lung Cancer; 2022 Jul; 169():47-54. PubMed ID: 35643060
[TBL] [Abstract][Full Text] [Related]
36. A risk-based framework for assessing real-time lung cancer screening eligibility that incorporates life expectancy and past screening findings.
Toumazis I; Alagoz O; Leung A; Plevritis SK
Cancer; 2021 Dec; 127(23):4432-4446. PubMed ID: 34383299
[TBL] [Abstract][Full Text] [Related]
37. Lung Cancer Screening Inconsistent With U.S. Preventive Services Task Force Recommendations.
Richards TB; Doria-Rose VP; Soman A; Klabunde CN; Caraballo RS; Gray SC; Houston KA; White MC
Am J Prev Med; 2019 Jan; 56(1):66-73. PubMed ID: 30467092
[TBL] [Abstract][Full Text] [Related]
38. Use of Statins for Primary Prevention: Selection of Risk Threshold and Implications Across Race and Gender.
Goyal A; Cooper HA; Aronow WS; Nagpal P; Yandrapalli S; Nabors CC; Frishman WH
Am J Med; 2018 Oct; 131(10):1234-1237. PubMed ID: 29928863
[TBL] [Abstract][Full Text] [Related]
39. One in five hepatocellular carcinoma patients in the United States are Hispanic while less than 40% were eligible for liver transplantation.
Robinson A; Ohri A; Liu B; Bhuket T; Wong RJ
World J Hepatol; 2018 Dec; 10(12):956-965. PubMed ID: 30631400
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
